21
www.diahome.org

DIA Imran Ali Quintiles Pharmacovigilance.ppt

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: DIA Imran Ali Quintiles Pharmacovigilance.ppt

www.diahome.org

Page 2: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Disclaimer

The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. (“DIA”), its directors, officers, employees, volunteers, members, chapters, councils, Special Interest Area Communities or affiliates, or any organization with which the presenter is employed or affiliated.

www.diahome.org

employed or affiliated.

These PowerPoint slides are the intellectual property of the individual presenter and are protected under the copyright laws of the United States of America and other countries. Used by permission. All rights reserved. Drug Information Association, DIA and DIA logo are registered trademarks or trademarks of Drug Information Association Inc. All other trademarks are the property of their respective owners.

Page 3: DIA Imran Ali Quintiles Pharmacovigilance.ppt

PharmacovigilanceMetrics Management & Operations

Oversight

www.diahome.org

Mir Imran Ali M.Pharm, M.B.A, CCDM, PMP

Associate Director

Pharmacovigilance Center

Quintiles India - Bangalore

Page 4: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Overview

• Introduction to Pharmacovigilance Operations

• Key Performance Indicators

• Balanced Scorecard

• Dashboard

www.diahome.org

• Dashboard

• Anticipated Challenges

• Ingredients for a successful Metrics

Page 5: DIA Imran Ali Quintiles Pharmacovigilance.ppt

www.diahome.org

Page 6: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Activities in Pharmacovigilance Operations

www.diahome.org

Page 7: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Why Do we need Metrics ?

• To measure the organizational performance

– “You can’t manage something that you can’t

measure”

www.diahome.org

• To facilitate the management to track and analyze

the performance of the business unit

• To ensure managerial effectiveness by providing

access to summarized information on various

performance metrics

Page 8: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Ascertaining KPIs

• Outline the strategy map based on the Balanced

Scorecard Methodology

• Feature four perspectives:

– Finance, Customer, Process and Learning and

www.diahome.org

– Finance, Customer, Process and Learning and

Growth

• Ascertain strategies under each perspective

• Determine a set of measures for each strategy

• Present a drill down of these measures to the

Functional Heads/relevant stakeholders

Page 9: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Balanced Score Card

• BSC is an approach in strategic management developed

in the early 1990's by Dr. Robert Kaplan and Dr. David

Norton

www.diahome.org

• It measures if an organization is meeting its objectives in

terms of vision and strategy

• BSC provides a comprehensive view thereby enabling

the organization to work on their best long term interests

Page 10: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Overview of the Balanced ScorecardOverview of the Balanced Scorecard

Vision

Strategy

www.diahome.org

Strategy

Critical Success Factors

Organizational

Learning

Internal

Business

Process

CustomerFinancial

KPIs

StrategicInitiatives

Page 11: DIA Imran Ali Quintiles Pharmacovigilance.ppt

A BSC Strategy Approach

www.diahome.org

Page 12: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Present it on a Dashboard!

• Once KPIs are in place, create a dashboard containing all the key performance indicators with a snapshot of the defined metrics

• Provide relevant access to key stakeholders which would give the individual a glimpse of the organizational performance across the four perspectives

www.diahome.org

across the four perspectives

– Different level of information will be required for different stakeholders

– This will extend managerial vision provide easy and quick access to summarized information

• Presenting the information on a defined 6 month/12 month rolling period along with coloured (Green, Yellow and Red) indicators will clearly indicate the direction the organization is heading on its various Strategic Objectives

Page 13: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Anticipated Challenges

• Limited automated processes and therefore largely dependant on manual data.

• Extensive involvement required from all stakeholders to define:

– KPIs

www.diahome.org

– KPIs

– Formulas to be used

– Frequency of reporting

– Identification of owners for each metric

• Metrics integrity by automating and validation of all key metrics

Page 14: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Anticipated Challenges contd…

• Working with multiple platforms is challenging

• Operational staff usually focus more on projects

delivery and do not consider providing information

www.diahome.org

delivery and do not consider providing information

for metrics high on their priority list

• Involvement of different support functions such as

Finance, Training, QA and HR adds to the

complexity

Page 15: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Ingredients for a successful Metrics

• Ensure buy-in from Senior Management is involved

• KPIs should be linked to business strategies

• Make it everyone’s job. Align it to performance goals and

incentives

www.diahome.org

• Use it as a tool for:

– Continuous communication on

the Organizational Performance

– Empower the workforce

– Continuous improvement

– Sharing of learnings

Page 16: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Metrics Approach - Dashboard

www.diahome.org

Metric Name

Contract Definition

SLA measure

Criteria

Reporting elements

Formulae

Frequency of metric collection

Page 17: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Success Story……

• In the Quintiles India Data Management group the metrics were driven by a Six Sigma approach where methodologies like BSC and Strategy Map were adopted.

• As a result they were able to:

– Achieve high visibility and acceptance on the importance of metrics

www.diahome.org

– Get buy in from key stake holders

– Make it everyone’s job

– Ensure that the right metrics were monitored/had a plan to be monitored

– See that all metrics had a clear and agreed definition, formula, methodology of data collecting, frequency of reporting etc. and everything was clearly documented.

– Put in place a process to review the metrics on a periodic basis

• Learning from this team was adopted by the Pharmacovigilance Center

Page 18: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Acknowledgements

• Mr. Suresh Ramu Vice President and Regional Head, Asia, CDM

• Mr. Jacques Watson Senior Director and Head of Programming

• Ms. Susan Watson Senior Director, Pharmacovigilance Center

www.diahome.org

• Ms. Susan Watson

• Ms. Nagalakshmi Shetty Manager, Clinical Data Management

• Mr. Rajesh Reddy Operations Scientist

Page 19: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Together we can “Improve Safety Profile, Promote Rational Use”

www.diahome.org

Page 20: DIA Imran Ali Quintiles Pharmacovigilance.ppt

www.diahome.org

Page 21: DIA Imran Ali Quintiles Pharmacovigilance.ppt

Thank You

[email protected]

www.diahome.org